Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 1
2020 1
2021 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Lactobacillus reuteri LRE02-Lactobacillus rhamnosus LR04 combination and gastrointestinal functional disorders in an Emergency Department pediatric population.
Margiotta G, Ferretti S, Graglia B, Gatto A, Capossela L, Bersani G, Curatola A, Chiaretti A. Margiotta G, et al. Eur Rev Med Pharmacol Sci. 2021 Apr;25(7):3097-3104. doi: 10.26355/eurrev_202104_25564. Eur Rev Med Pharmacol Sci. 2021. PMID: 33877678 Free article.
The objective of this study was to evaluate treatment effectiveness, safety, and palatability of a probiotic's combination (Lactobacillus reuteri LRE02-DSM 23878 and Lactobacillus rhamnosus LR04-DSM 16605) in a pediatric Emergency …
The objective of this study was to evaluate treatment effectiveness, safety, and palatability of a probiotic's combination (Lactobacillus …
Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form.
Piano MD, Carmagnola S, Ballarè M, Balzarini M, Montino F, Pagliarulo M, Anderloni A, Orsello M, Tari R, Sforza F, Mogna L, Mogna G. Piano MD, et al. J Clin Gastroenterol. 2012 Oct;46 Suppl:S85-92. doi: 10.1097/MCG.0b013e3182672796. J Clin Gastroenterol. 2012. PMID: 22955366 Clinical Trial.
In particular, subjects were divided into 2 groups: group A (27 subjects) was given a mix of probiotic strains Probiotical S.p.A. (Novara, Italy), Lactobacillus acidophilus LA02 (DSM 21717), Lactobacillus rhamnosus LR04 (DSM 16605) …
In particular, subjects were divided into 2 groups: group A (27 subjects) was given a mix of probiotic strains Probiotical S.p.A. (Novara, I …
Effect of Limosilactobacillus reuteri LRE02-Lacticaseibacillus rhamnosus LR04 Combination on Antibiotic-Associated Diarrhea in a Pediatric Population: A National Survey.
Drago L, Meroni G, Chiaretti A, Laforgia N, Cucchiara S, Baldassarre ME, On Behalf Of The Surveyflor Group. Drago L, et al. J Clin Med. 2020 Sep 24;9(10):3080. doi: 10.3390/jcm9103080. J Clin Med. 2020. PMID: 32987822 Free PMC article.
The objective of this study was to evaluate the benefits of a probiotic combination (Limosilactibacillus reuteri LRE02-DSM 23878 and Lacticaseibacillus rhamnosus LR04-DSM 16605) on the prevention of AAD in an outpatient pediatric setting. …
The objective of this study was to evaluate the benefits of a probiotic combination (Limosilactibacillus reuteri LRE02-DSM 23878 and …
Evaluation of main functional dyspepsia symptoms after probiotic administration in patients receiving conventional pharmacological therapies.
Drago L, Meroni G, Pistone D, Pasquale L, Milazzo G, Monica F, Aragona S, Ficano L, Vassallo R; Gastrobiota Group. Drago L, et al. J Int Med Res. 2021 Jan;49(1):300060520982657. doi: 10.1177/0300060520982657. J Int Med Res. 2021. PMID: 33472489 Free PMC article.
This work aims to evaluate a probiotic combination of Lacticaseibacillus rhamnosus LR04 (DSM 16605), Lactiplantibacillus pentosus LPS01 (DSM 21980), Lactiplantibacillus plantarum LP01 (LMG P-21021), and Lactobacillus delbrueckii su …
This work aims to evaluate a probiotic combination of Lacticaseibacillus rhamnosus LR04 (DSM 16605), Lact …
In Vitro Inhibition of Klebsiella pneumoniae by Lactobacillus delbrueckii Subsp. delbrueckii LDD01 (DSM 22106): An Innovative Strategy to Possibly Counteract Such Infections in Humans?
Mogna L, Deidda F, Nicola S, Amoruso A, Del Piano M, Mogna G. Mogna L, et al. J Clin Gastroenterol. 2016 Nov/Dec;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S136-S139. doi: 10.1097/MCG.0000000000000680. J Clin Gastroenterol. 2016. PMID: 27741158
GOALS: To determine the in vitro antimicrobial activity of selected Lactobacillus strains isolated from the feces of healthy humans against Klebsiella pneumoniae. ...These strains are particularly virulent, express capsular-type K55, and have a considerable ability to prop …
GOALS: To determine the in vitro antimicrobial activity of selected Lactobacillus strains isolated from the feces of healthy humans a …